{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:58:32Z","timestamp":1711648712674},"reference-count":22,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":7548,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1111\/j.1600-0404.1995.tb05834.x","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T23:02:17Z","timestamp":1236985337000},"page":"1-5","source":"Crossref","is-referenced-by-count":29,"title":["Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study"],"prefix":"10.1155","volume":"91","author":[{"given":"M. G.","family":"Marciani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Spanedda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Iani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"issue":"suppl. 2","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB1","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1111\/j.1528-1157.1984.tb05646.x","article-title":"Amino acid neurotransmitters and new approaches to anticonvulsant drug action.","volume":"25","author":"Meldrum","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.29.9_Part_1.1203","article-title":"Low cerebrospinal fluid \u03b3-aminobutyric acid content in seizure patients.","volume":"29","author":"Wood","year":"1979","journal-title":"Neurology (Minneap.)"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0006-8993(72)90141-2","article-title":"Amino acid content of epileptogenic human brain: focal versus surrounding regions.","volume":"40","author":"Gelder","year":"1972","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-8993(79)90824-2","article-title":"The relationship between GABA concentrations in brain and cerebrospinal fluid.","volume":"167","author":"Bohlen","year":"1979","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB5","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/0024-3205(81)90511-7","article-title":"Increased gamma-aminobutyric acid (GABA), homocarnosine and \u03b2-alanine in cerebrospinal fluid of patients treated with \u03b3-vinyl GABA (4-amino-hex-5-enoic acid).","volume":"28","author":"Grove","year":"1981","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.34.2.182","article-title":"Biochemical and clinical effects of gammavinyl-GABA in patients with epilepsy.","volume":"34","author":"Schechter","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB7","first-page":"937","volume-title":"Antiepileptic drugs","author":"Richens","year":"1989"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ana.410170307","article-title":"\u03b3-vinyl-GABA: a double-blind placebo-controlled trial in partial epilepsy.","volume":"17","author":"Gram","year":"1985","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1528-1157.1986.tb03600.x","article-title":"Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study.","volume":"27","author":"Tartara","year":"1986","journal-title":"Epilepsia"},{"issue":"2","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1528-1157.1986.tb03512.x","article-title":"Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.","volume":"27","author":"Loiseau","year":"1986","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.37.2.184","article-title":"Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.","volume":"37","author":"Browne","year":"1987","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1212\/WNL.41.4.562","article-title":"Vigabatrin in drug-resistant partial epilepsy: a 5-year follow up study.","volume":"41","author":"Sivenius","year":"1991","journal-title":"Neurology"},{"issue":"4","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1991.tb04688.x","article-title":"Open, double-blind and long-term study of vigabatrin in chronic epilepsy.","volume":"32","author":"Reynolds","year":"1991","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.1985.tb00873.x","article-title":"Long-term study of gamma-vinyl GABA in the treatment of epilepsy.","volume":"72","author":"Pedersen","year":"1985","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1528-1157.1989.tb05322.x","article-title":"Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study.","volume":"30","author":"Luna","year":"1989","journal-title":"Epilepsia"},{"issue":"suppl. 2","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB16","first-page":"2530","article-title":"Vigabatrin in childhood epilepsy.","volume":"6","author":"Dulac","year":"1991","journal-title":"J Child Neurol"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(84)92112-3","article-title":"Double-blind study of \u03b3-vinyl GABA in patients with refractory epilepsy.","volume":"1","author":"Rimmer","year":"1984","journal-title":"The Lancet"},{"key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archneur.1987.00520210009010","article-title":"Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy.","volume":"44","author":"Tassinari","year":"1987","journal-title":"Arch Neurol"},{"issue":"suppl. 2","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB19","doi-asserted-by":"crossref","first-page":"2S60","DOI":"10.1177\/0883073891006002111","article-title":"Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.","volume":"6","author":"K\u00e4lvi\u00e4inen","year":"1991","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1528-1157.1992.tb02201.x","article-title":"\u03b3-vinyl GABA (vigabatrin) in epilepsy: clinical, neurochemical and neurophysiology monitoring in epileptic patients.","volume":"33","author":"Ylinen","year":"1992","journal-title":"Epilepsia"},{"issue":"5","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1528-1157.1987.tb03680.x","article-title":"Carbamazepine-induced nonepileptic myoclonus in a child with benign epilepsy.","volume":"28","author":"Aguglia","year":"1987","journal-title":"Epilepsia"},{"issue":"suppl. 5","key":"10.1111\/j.1600-0404.1995.tb05834.x-BIB22","first-page":"S3","article-title":"GABA and epilepsy: basic concepts from preclinical research.","volume":"33","author":"Gala","year":"1992","journal-title":"Epilepsia"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1995.tb05834.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1995.tb05834.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:42:57Z","timestamp":1671540177000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1995.tb05834.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb05834.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}